William N. Washburn
Bristol-Myers Squibb (Germany)(DE)Bristol-Myers Squibb (Sweden)(SE)
Publications by Year
Research Areas
Diabetes Treatment and Management, Crystallization and Solubility Studies, Pharmacology and Obesity Treatment, X-ray Diffraction in Crystallography, Metabolism, Diabetes, and Cancer
Most-Cited Works
- → Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes(2008)617 cited
- → Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats(2008)417 cited
- → Development of the Renal Glucose Reabsorption Inhibitors: A New Mechanism for the Pharmacotherapy of Diabetes Mellitus Type 2(2009)155 cited
- → [1] Assay strategies and methods for phospholipases(1991)114 cited
- → Evolution of sodium glucose co-transporter 2 inhibitors as anti-diabetic agents(2009)84 cited
- → Differentiating sodium-glucose co-transporter-2 inhibitors in development for the treatment of type 2 diabetes mellitus(2013)82 cited